{
  "id": "641368ee201352f04a00003c",
  "type": "list",
  "question": "What are the  types/categories of adult diffuse gliomas.",
  "ideal_answer": "The four main types/categories of adult diffuse gliomas are:\n\n1. Astrocytomas\n2. Oligodendrogliomas\n3. Mixed Gliomas\n4. Ependymomas",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/25744348",
    "http://www.ncbi.nlm.nih.gov/pubmed/25641008",
    "http://www.ncbi.nlm.nih.gov/pubmed/16700618",
    "http://www.ncbi.nlm.nih.gov/pubmed/35587830",
    "http://www.ncbi.nlm.nih.gov/pubmed/35876874",
    "http://www.ncbi.nlm.nih.gov/pubmed/30148717",
    "http://www.ncbi.nlm.nih.gov/pubmed/32640746",
    "http://www.ncbi.nlm.nih.gov/pubmed/36006639",
    "http://www.ncbi.nlm.nih.gov/pubmed/28339700",
    "http://www.ncbi.nlm.nih.gov/pubmed/31175262",
    "http://www.ncbi.nlm.nih.gov/pubmed/36299937",
    "http://www.ncbi.nlm.nih.gov/pubmed/21889777",
    "http://www.ncbi.nlm.nih.gov/pubmed/34729052",
    "http://www.ncbi.nlm.nih.gov/pubmed/35562130"
  ],
  "snippets": [
    {
      "text": " Adult-type diffuse gliomas are genetically defined and include astrocytoma, isocitrate dehydrogenase (IDH)-mutant, oligodendroglioma, IDH-mutant and 1p/19q codeleted, and glioblastoma, IDH-wildtype",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35562130",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " According to the 2021 World Health Organization classification, the three risk types included (1) low-risk, expecting oligodendroglioma, isocitrate dehydrogenase (IDH)-mutant, and 1p/19q-codeleted; (2) intermediate-risk, expecting astrocytoma, IDH-mutant; and (3) high-risk, expecting glioblastoma, IDH-wildtype.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35587830",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Adult-type diffuse gliomas are genetically defined and include astrocytoma, isocitrate dehydrogenase (IDH)-mutant, oligodendroglioma, IDH-mutant and 1p/19q codeleted, and glioblastoma, IDH-wildtype.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35562130",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "A review of adult-type diffuse gliomas in the WHO CNS5 classification with special reference to Astrocytoma, IDH-mutant and Oligodendroglioma, IDH-mutant and 1p/19q codeleted.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35562130",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "thogenesis and prognosis. Furthermore, the previous broad category of adult-type diffuse gliomas has been consolidated into 3 types: astrocytoma, isocitrate dehydrogenase (IDH) mutant; oligodendroglioma, IDH mutant and 1p/19q codeleted; and gl",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/36006639",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "This review briefly discusses two tumor types: astrocytoma, IDH-mutant, and oligodendroglioma, IDH-mutant and 1p/19q codeleted, with emphasis on relevant changes in their classification and defining molecular genetic alterations.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35562130",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Since brainstem biopsies are rarely performed, these tumours are commonly classified according to their MR imaging characteristics into 4 subgroups: (a) diffuse intrinsic low-grade gliomas, (b) enhancing malignant gliomas, (c) focal tectal gliomas and (d) exophytic gliomas/other subtypes.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25641008",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "C\u2009>\u20090.5, k\u2009>\u20090.6, p\u2009<\u20090.001). IBGS type-I, type-II, and type-III gliomas had good specificity in identifying IDHmut 1p19q-codel oligodendroglioma (training - 97%, validation - 85%); IDHmut 1p19q non-codel astrocytoma (training - 80%, validation - 85.9%); and IDHwt glioblastoma (training - 76.5%, validation- 87.3%) respectively (p-value\u2009<\u20090.01).CONCLUSIONS: Imaging-based stratification of adult diffuse gliomas predicted patient survival and correlate",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35876874",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In the new WHO classification 2021, adult-type diffuse astrocytic gliomas subdivide into isocitrate dehydrogenase (IDH)-mutant astrocytoma, IDH-mutant and 1p/19q-codeleted oligodendroglioma, and IDH-wildtype glioblastoma.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/36299937",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Recent genetic studies have revealed that the major categories of gliomas, such as circumscribe astrocytomas, infiltrating astrocytomas/oligodendrogliomas, and glioblastoma, roughly correspond to major genetic alterations, including isocitrate dehydrogenases (IDHs) 1/2 mutations, TP53 mutations, co-deletion of chromosome arms 1p/19q, and BRAF mutation/fusion.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25744348",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "This improves diagnostic accuracy and prognostication: oligo-astrocytoma no longer exists as a clinical entity; isocitrate dehydrogenase (IDH) mutant and 1p/19q co-deleted oligodendroglioma is a smaller category with better prognosis; IDH wild-type 'low-grade' glioma has a much poorer prognosis; and glioblastoma is divided into IDH mutant (with an better prognosis than pre-2016 glioblastoma) and IDH wild type (with a poorer prognosis).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31175262",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "A four-tiered WHO grading scheme has been successfully applied to a spectrum of diffusely infiltrative astrocytomas, but it is not fully applicable to other gliomas, including oligodendrogliomas and ependymomas.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25744348",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "This has resulted in a major revision of the WHO classification, which is now for adult diffuse glioma centered around isocitrate dehydrogenase (IDH) and 1p/19q diagnostics.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28339700",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The major representatives in this subgroup are the diffuse astrocytic, oligodendroglial, and mixed oligo-astrocytic tumors.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16700618",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " The major representatives in this subgroup are the diffuse astrocytic, oligodendroglial, and mixed oligo-astrocytic tumors.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16700618",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "ssion, and 1p/19q co-deletion detection in adult diffuse gliomas (Grade II, III, and IV) and to correlate them with clinicopathological and histopatho",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34729052",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "vide into isocitrate dehydrogenase (IDH)-mutant astrocytoma, IDH-mutant and 1p/19q-codeleted oligodendroglioma, and IDH-wildtype glioblastoma. The T2-",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/36299937",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "include astrocytoma, isocitrate dehydrogenase (IDH)-mutant, oligodendroglioma, IDH-mutant and 1p/19q codeleted, and glioblastoma, IDH-wildtype. This r",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35562130",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "hese changes has been the division of adult astrocytomas into IDH-wildtype and IDH-mutant categories in addition to histologic grade as part of the ma",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32640746",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "O classification, five main molecular subgroups of adult diffuse gliomas can be distinguished based on the 1p/19q codeletion, isocitrate dehydrogenase (IDH), and histone H3.3 mutation status. In the future, this cla",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30148717",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Adult gliomas are most often infiltrative. The World Health Organization (WHO) has classed them into three major groups according to the presomptive cell of origin: astrocytoma, oligodendroglioma and mixed oligoastrocytoma. Depending on the presence or absence of a small number of signs of anaplasia (mitosis, nuclear atypia, cell density, microvascular proliferation and necrosis) the WHO distinguishes grade II (LGG), III (anaplastic), and IV (glioblastomas, GBM).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21889777",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "astrocytoma, oligodendroglioma, glioblastoma, isocitrate dehydrogenase (IDH)-mutant,, 1p/19q codeleted, IDH-wildtype, glioblastoma, IDH wildtype, ependyoma"
}